Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 86,742 | 82,491 | 68,778 | 79,545 | 75,827 |
| Cost of Goods | 1,099 | 894 | 931 | 2,383 | 3,543 |
| Gross Profit | 85,643 | 81,597 | 67,847 | 77,162 | 72,284 |
| Operating Expenses | 97,663 | 103,194 | 97,193 | 123,860 | 90,272 |
| Operating Income | -11,921 | -20,703 | -28,415 | -46,311 | -17,445 |
| Interest Expense | 27,345 | 28,915 | 27,396 | 26,458 | 24,775 |
| Other Income | 3,447 | -24,968 | 3,149 | 1,304 | 1,222 |
| Pre-tax Income | -35,819 | -74,586 | -52,662 | -71,465 | -40,998 |
| Income Tax | 330 | 740 | 671 | 76 | 1,522 |
| Net Income Continuous | -36,149 | -75,326 | -53,333 | -71,541 | -42,520 |
| Net Income | $-36,149 | $-75,326 | $-53,333 | $-71,541 | $-42,520 |
| EPS Basic Total Ops | -0.19 | -0.40 | -0.28 | -0.38 | -0.23 |
| EPS Basic Continuous Ops | -0.19 | -0.40 | -0.28 | -0.38 | -0.23 |
| EPS Diluted Total Ops | -0.19 | -0.40 | -0.28 | -0.38 | -0.23 |
| EPS Diluted Continuous Ops | -0.19 | -0.40 | -0.28 | -0.38 | -0.23 |
| EBITDA(a) | $-14,098 | $-23,128 | $-29,395 | $-46,878 | $-17,786 |